Q. Consider the following statements regarding Pembrolizumab:
1.It is a monoclonal antibody used in cancer immunotherapy.
2.It is primarily used as an antibiotic to treat bacterial infections such as tuberculosis.
Which of the statements given above is/are correct?
Answer: A
Notes:
Explanation: 1 only
Statement 1 is correct: Pembrolizumab is an immune checkpoint inhibitor (anti-PD-1) used in treating various cancers.
Statement 2 is incorrect: It is not an antibiotic; it is used in oncology (cancer treatment).
Source: IE
